Tag: COMT inhibitor

Opicapone: follow-up on the BIPARK I and II trials

Presented By

Prof. Joaquim J. Ferreira, Laboratorio de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Portugal

Trial

Phase 3, BIPARK-I and BIPARK-II

Conference

EAN 2019